Verified ProfileEN

KPC Pharmaceuticals,Inc.

Order verification — $199

Manufacturing · Chemical Pharmaceutical Raw Material Manufacturing

Verification dossier

KPC Pharmaceuticals,Inc. is a Chinese company based in Kunming, Yunnan. The company operates in the chemical pharmaceutical raw material manufacturing sector, within the broader manufacturing industry. Established 1995, the company has been operating for 31 years.

Sinolinks tracks KPC Pharmaceuticals,Inc. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

Procurement, production, and sales of Chinese and Western medicine raw materials and preparations, chemical raw materials, intermediates, reagents, packaging materials, extracts, and traditional Chinese medicine decoction pieces. Planting, acquisition, and sales of agricultural and sideline products and traditional Chinese medicinal materials. Industrial hemp cultivation, R&D, flower and leaf processing, domestic trade, material supply and marketing. Import and export of goods and technology. Technology development, consulting services, mechanical processing, pharmaceutical equipment manufacturing, installation, and maintenance services. Pharmaceutical engineering design. Foreign aid material projects.

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review